A Study of Aneustat (OMN54) in Patients With Advanced Cancer and Lymphomas

NCT01555242 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Aneustat (OMN54)

Sponsor

Omnitura Therapeutics, Inc.